SPRI | Methods And Biostatistics In Oncology (2018 EN)

Discussion in 'Medicine' started by Kanka, May 25, 2018.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,037
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Raphael. L.C Araújo (Editor), Rachel P. Riechelmann (Editor)
    Full Title: Methods And Biostatistics In Oncology: Understanding Clinical Research As An Applied Tool
    Publisher: Springer; 1st ed. 2018 edition (April 17, 2018)
    Year: 2018
    ISBN-13: 9783319713243 (978-3-319-71324-3), 9783319713236 (978-3-319-71323-6)
    ISBN-10: 3319713248, 331971323X
    Pages: 348
    Language: English
    Genre: Medicine: Oncology
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 117.69 €


    This book introduces and discusses the most important aspects of clinical research methods and biostatistics for oncologists, pursuing a tailor-made and practical approach. Evidence-based medicine (EBM) has been in vogue in the last few decades, particularly in rapidly advancing fields such as oncology. This approach has been used to support decision-making processes worldwide, sparking new clinical research and guidelines on clinical and surgical oncology. Clinical oncology research has many peculiarities, including specific study endpoints, a special focus on survival analyses, and a unique perspective on EBM. However, during medical studies and in general practice, these topics are barely taught. Moreover, even when EBM and clinical cancer research are discussed, they are presented in a theoretical fashion, mostly focused on formulas and numbers, rather than on clinical application for a proper literature appraisal. Addressing that gap, this book discusses more practical aspects of clinical research and biostatistics in oncology, instead of relying only on mathematical formulas and theoretical considerations. Methods and Biostatistics in Oncology will help readers develop the skills they need to understand the use of research on everyday oncology clinical practice for study design and interpretation, as well to demystify the use of EBM in oncology.

    -------------
     
    Last edited by a moderator: Nov 30, 2019